Non-Interventional, Postmarketing Surveillance Study of Nusinersen Sodium Injection
NCT04419233
·
clinicaltrials.gov ↗
COMPLETED
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
Muscular Atrophy, Spinal
Interventions
DRUG:
Nusinersen Sodium Injection
Sponsor
Biogen